Melvin Munsaka

Cardiovascular safety of the dipetidyl peptidase‐4 inhibitor alogliptin in type 2 diabetes mellitus

William B. White, Richard E. Pratley, P. Fleck et al. · Diabetes Obesity and Metabolism · 2013 · 117 citations

The Effects of Psychotherapy, Nefazodone, and Their Combination on Subjective Assessment of Disturbed Sleep in Chronic Depression

Rachel Manber, A. John Rush, Michael E. Thase et al. · SLEEP · 2003 · 102 citations

Randomized, Placebo-Controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression

Alan J. Gelenberg, Madhukar H. Trivedi, A. John Rush et al. · Biological Psychiatry · 2003 · 78 citations

Nefazodone Maintenance Treatment, Psychiatry, Depression Treatment +10

Liver Safety of Fasiglifam (TAK-875) in Patients with Type 2 Diabetes: Review of the Global Clinical Trial Experience

John Marcinak, Melvin Munsaka, Paul B. Watkins et al. · Drug Safety · 2018 · 45 citations

Metabolic Syndrome, Hepatology, Medicine +9

Coadministration of Pioglitazone or Glyburide and Alogliptin: Pharmacokinetic Drug Interaction Assessment in Healthy Participants

Aziz Karim, Aziz Laurent, Melvin Munsaka et al. · The Journal of Clinical Pharmacology · 2009 · 34 citations

Drug Interactions, Therapeutic Drug Monitoring, Diabetes Management +11